Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
New research indicates proportion of young women who have never been screened for cervical cancer more than doubled since 2005
Developed by a British firm, the test will be available as a $29 add-on to pricier genetic profiling assays
Clinical laboratories may soon be able to use a simplified LDL cholesterol calculation
The personalized test is designed to help inform post-surgery adjuvant therapies in CRC patients.
Principal investigator discusses a new research initiative to create a low-cost, rapid HIV self-test.
Researchers found that combining AI with both imaging technologies can improve the detection of cancer in women with dense breasts.
According to the FDA’s recently-released annual report, only 135 devices received the designation last year, versus 213 in 2021.
A new method for early detection of 14 cancer types based on glycosaminoglycan profiles shows promise.
The panel recently said there was still not enough evidence to properly assess the harms and benefits of such screening.
An overview of what will happen to the COVID-19 tests issued via EUA once the public health emergency ends on May 11.
Researchers report the first-ever routine clinical use of an AI-based tool for breast cancer biopsies in a pathology lab.
Experts share new strategies for dealing with hemolysis, icterus, and lipemia interference.
In a new practice guideline, the group also “strongly recommends” that NIPS be offered to patients to screen for fetal SCA.